GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$157.38
Tradestie Score
49
Market Cap
$7.81B
Revenue Growth
0.4%
Analyst Upside
+23.5%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MTD
Mettler-Toledo International
|
$1293.52
|
$26.57B | 28.9 | 44 | Compare |
|
DXCM
DexCom, Inc.
|
$83.03
|
$25.91B | 33.1 | 40 | Compare |
|
LH
Labcorp Holdings Inc.
|
$311.54
|
$23.19B | 25.4 | 44 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$328.93
|
$22.18B | - | 47 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$235.02
|
$20.36B | 24.5 | 48 | Compare |
|
WAT
Waters Corp
|
$408.34
|
$19.04B | 101.9 | 59 | Compare |
|
ILMN
Illumina Inc
|
$206.45
|
$15.72B | 37.6 | 39 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$587.52
|
$15.28B | 34.5 | 42 | Compare |
|
ICLR
Icon Plc
|
$169.31
|
$14.96B | 243.7 | 60 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
More GH Analysis
Data updated: Sep 12, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry